Think of all the companies that make their money on ad revenue. Besides the on-line newspapers and search engines, there are all the social media sites. Several of the biggest market cap companies fall into the "ad revenue" category. If the economy isn't growing, how can these companies continue to grow?
Check out RGDX, a competitor of CGIX. Market cap is about $40 million and the news is comparable to ROSG. Could it be that this industry is just doomed to low sales and no profits? Obviously some of the big labs are doing just fine, but these small companies just can't get any traction.
Let's see. that means the buyers of the last secondary have only lost 40% of their money rather than 50%. Wow, there's nothing like that feeling of being less poor.
Yesterday CLF went up, MCP didn't. Today CLF is down, but MCP is down more. While MCP doesn't mine precious metals, you'd think that there would be some correlation between miners. PAAS is up 6% today. It would seem the smart move is to short MCP and go long any other miner.
OK, so their bid of $3 billion was rejected and the stock price went up? I don't understand. Was it the fact that they saved $3 billion? Sorry, but ever since my neighbor's FB page was hacked, I dropped my account. I missed it for about a week. Now I know it was the right decision.
Seems more like signs of something snoozing. Only about $100K shares traded today and no posts on this board. That's a sure sign of snoozing.
Lots of folks here seem to like MCP, but their faith has not been rewarded. Share price just doesn't move up, no matter what the market does. So, let me suggest you sell an in the money put. The Dec 5 is going for about 50 cents. If share price continues to go down, you break even if it closes at 4,50. Anything above that and you make a few dollars. Obviously your upside is limited with this strategy, but greed is not rewarded with this stock.
Both of these are miners and so they should move in tandem. CLF has recovered all of yesterday's drop, but MCP is only pennies above its 52 week low. Sorry, MCP seems to go down on a weak market and doesn't participate in a strong market. Until we see some upside movement, retail investors aren't going to tie up their money in MCP.
Again, there was a merger in the biotech sector. VPHM is being bought out for a nice premium. This news has pushed some other biotechs up. ROSG? It is just snoozing at about $2.50.
You mean 5.13 - 5.19? Recently any price above 5.00 brought out the sellers. I don't see any reason to believe that will change soon.
OK. Then buy the Dec calls at $6 strike price. For the price of 1000 shares of MCP, you could buy contracts on nearly 100,000 shares.
Sorry. Options expire this week. There are 17,000 calls at 5. The big boys aren't going to let the price move above 5 until after the options expire.
It is the GS price target of $5. Weve got options expiring today and GS certainly doesn't want anyone to make any money on $5 calls. Sorry, but I'm convinced there are too many people on the opposite side of these trades who want to take your money.
Easy. GS still has a $5 price target on MCP. There will be covering, but the GS price target will prevent it from getting out of hand.
GS must be trading this one for their own account. All last week we saw the price hover around 5. Can that be a surprise?
Of course you could have said that any day in the last several years. It has sunk to new lows on a countless number of days.
This is the second "treatment patent" recently announced. I think it is positive, but I don't understand why ROSG is trying to go it alone. ALNY has numerous partnerships to help them develop RNAI based treatments and look at their market cap.